Competitive AMPA antagonism: a novel mechanism for antiepileptic drugs?

被引：20

作者：

Auberson, YP ^{[1
]}

机构：

[1] Novartis Pharma AG, Nervous Syst Res, CH-4002 Basel, Switzerland

来源：

DRUGS OF THE FUTURE | 2001年 / 26卷 / 05期

关键词：

D O I：

10.1358/dof.2001.026.05.659545

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

[No abstract available]

引用

页码：463 / 471

页数：9

共 90 条

[61]

2-F

[62] AMPA/kainate antagonist LY293558 reduces capsaicin-evoked hyperalgesia but not pain in normal skin in humans [J].

Sang, CN ;

Hostetter, MP ;

Gracely, RH ;

Chappell, AS ;

Schoepp, DD ;

Lee, G ;

Whitcup, S ;

Caruso, R ;

Max, MB .

ANESTHESIOLOGY, 1998, 89 (05) :1060-1067

[63] REPORT OF IFCN COMMITTEE ON CLINICAL RELEVANCE OF KINDLING - KINDLING - BASIC MECHANISMS AND CLINICAL VALIDITY [J].

SATO, M ;

RACINE, RJ ;

MCINTYRE, DC .

ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY, 1990, 76 (05) :459-472

[64] RELEVANCE OF KINDLING AND RELATED PROCESSES TO HUMAN EPILEPTOGENESIS [J].

SCHMUTZ, M .

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1987, 11 (04) :505-525

[65]

SCHMUTZ M, UNPUB AMP397A ORALLY

[66] IN-VITRO AND IN-VIVO ANTAGONISM OF AMPA RECEPTOR ACTIVATION BY (3S,4AR,6R,8AR)-6-[2-(1(2)H-TETRAZOLE-5-YL)ETHYL]DECAHYDROISOQUINOLINE-3-CARBOXYLIC ACID [J].

SCHOEPP, DD ;

LODGE, D ;

BLEAKMAN, D ;

LEANDER, JD ;

TIZZANO, JP ;

WRIGHT, RA ;

PALMER, AJ ;

SALHOFF, CR ;

ORNSTEIN, PL .

NEUROPHARMACOLOGY, 1995, 34 (09) :1159-1168

[67] An overview of the preclinical aspects of topiramate: Pharmacology, pharmacokinetics, and mechanism of action [J].

Shank, RP ;

Gardocki, JF ;

Streeter, AJ ;

Maryanoff, BE .

EPILEPSIA, 2000, 41 :S3-S9

[68] 2,3-DIHYDROXY-6-NITRO-7-SULFAMOYL-BENZO(F)QUINOXALINE - A NEUROPROTECTANT FOR CEREBRAL-ISCHEMIA [J].

SHEARDOWN, MJ ;

NIELSEN, EO ;

HANSEN, AJ ;

JACOBSEN, P ;

HONORE, T .

SCIENCE, 1990, 247 (4942) :571-574

[69]

ShimizuSasamata M, 1996, J PHARMACOL EXP THER, V276, P84

[70]

Skradski S, 2000, EPILEPSIA, V41, pS45

← 1 2 3 4 5 6 7 8 9 →